BEAM
Price
$16.87
Change
+$0.23 (+1.38%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
1.68B
74 days until earnings call
XNCR
Price
$8.02
Change
+$0.12 (+1.52%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
572.01M
75 days until earnings call
Interact to see
Advertisement

BEAM vs XNCR

Header iconBEAM vs XNCR Comparison
Open Charts BEAM vs XNCRBanner chart's image
Beam Therapeutics
Price$16.87
Change+$0.23 (+1.38%)
Volume$18.89K
Capitalization1.68B
Xencor
Price$8.02
Change+$0.12 (+1.52%)
Volume$7.96K
Capitalization572.01M
BEAM vs XNCR Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. XNCR commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and XNCR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (BEAM: $16.86 vs. XNCR: $8.02)
Brand notoriety: BEAM and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 63% vs. XNCR: 175%
Market capitalization -- BEAM: $1.68B vs. XNCR: $572.01M
BEAM [@Biotechnology] is valued at $1.68B. XNCR’s [@Biotechnology] market capitalization is $572.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • XNCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +4.98% price change this week, while XNCR (@Biotechnology) price change was +6.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.04%. For the same industry, the average monthly price growth was +19.75%, and the average quarterly price growth was +30.54%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+4.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.68B) has a higher market cap than XNCR($572M). BEAM YTD gains are higher at: -32.016 vs. XNCR (-65.622). XNCR has higher annual earnings (EBITDA): -125.38M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. XNCR (444M). XNCR has less debt than BEAM: XNCR (67.9M) vs BEAM (155M). XNCR has higher revenues than BEAM: XNCR (147M) vs BEAM (60.3M).
BEAMXNCRBEAM / XNCR
Capitalization1.68B572M294%
EBITDA-414.33M-125.38M330%
Gain YTD-32.016-65.62249%
P/E RatioN/AN/A-
Revenue60.3M147M41%
Total Cash1.15B444M259%
Total Debt155M67.9M228%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMXNCR
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 10 days ago
72%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BNIEX12.16N/A
N/A
UBS International Sustainable Equity A
HIGCX20.54N/A
N/A
Carillon Eagle Growth & Income C
TISDX12.00N/A
N/A
Transamerica Intl Sust Eq A
JDITX16.65N/A
N/A
JHancock Disciplined Value Intl R4
IVIAX24.55-0.12
-0.49%
Macquarie International Core Eq A

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-1.37%
CRNX - XNCR
62%
Loosely correlated
+2.79%
SYRE - XNCR
56%
Loosely correlated
+2.90%
BEAM - XNCR
55%
Loosely correlated
+1.22%
CGON - XNCR
54%
Loosely correlated
+6.33%
MGNX - XNCR
54%
Loosely correlated
+10.37%
More